168 related articles for article (PubMed ID: 3284830)
41. Effects of inhaled N-acetylcysteine in combination with terbutaline.
Stiksa G; Nemcek K; Melin S
Eur J Respir Dis; 1984 May; 65(4):278-82. PubMed ID: 6723838
[TBL] [Abstract][Full Text] [Related]
42. Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: a 15-day, prospective, parallel, open-label, pilot study.
Crisafulli E; Coletti O; Costi S; Zanasi E; Lorenzi C; Lucic S; Fabbri LM; Bertini M; Clini EM
Clin Ther; 2007 Sep; 29(9):2001-9. PubMed ID: 18035199
[TBL] [Abstract][Full Text] [Related]
43. S-carboxymethylcysteine in the fluidification of sputum and treatment of chronic airway obstruction.
Edwards GF; Steel AE; Scott JK; Jordan JW
Chest; 1976 Oct; 70(4):506-13. PubMed ID: 789027
[TBL] [Abstract][Full Text] [Related]
44. Mucus-controlling agents: past and present.
King M; Rubin BK
Respir Care Clin N Am; 1999 Dec; 5(4):575-94. PubMed ID: 10565882
[TBL] [Abstract][Full Text] [Related]
45. Nesosteine: a new mucoregulatory agent.
Scuri R; Mondani P; Frova C; Fantini L
Drugs Exp Clin Res; 1986; 12(8):663-70. PubMed ID: 3757762
[TBL] [Abstract][Full Text] [Related]
46. Effects of a short course of treatment with acebrophylline on the mucus rheological characteristics and respiratory function parameters in patients suffering from chronic obstructive pulmonary disease.
Agliati G
J Int Med Res; 1996; 24(3):302-10. PubMed ID: 8725993
[TBL] [Abstract][Full Text] [Related]
47. Oral neltenexine in patients with obstructive airways diseases: an open, randomised, controlled comparison versus sobrerol.
Fadda G
Minerva Med; 2001 Aug; 92(4):269-75. PubMed ID: 11535970
[TBL] [Abstract][Full Text] [Related]
48. Regeneration of changes induced in rabbit tracheal epithelium by a single oral dose of a mucolytic agent.
Konrádová V; Vávrová V; Sulová J
Folia Morphol (Praha); 1986; 34(1):52-8. PubMed ID: 3699638
[No Abstract] [Full Text] [Related]
49. Doxepin treatment of depressed patients with chronic obstructive pulmonary disease.
Light RW; Merrill EJ; Despars J; Gordon GH; Mutalipassi LR
Arch Intern Med; 1986 Jul; 146(7):1377-80. PubMed ID: 3521524
[TBL] [Abstract][Full Text] [Related]
50. [Mucolytic therapy for respiratory system diseases. Clinical-experimental results before and after treatment with Transbronchin].
Primer G
Ther Ggw; 1975 Aug; 114(8):1251-66. PubMed ID: 1108276
[No Abstract] [Full Text] [Related]
51. The effect of mucolytic agents on the rheologic and transport properties of canine tracheal mucus.
Puchelle E; Sadoul P
Am Rev Respir Dis; 1980 Nov; 122(5):808-9. PubMed ID: 7447163
[No Abstract] [Full Text] [Related]
52. Model systems for the evaluation of mucolytic drugs: acetylcysteine and S-carboxymethylcysteine.
Livingstone CR; Andrews MA; Jenkins SM; Marriott C
J Pharm Pharmacol; 1990 Feb; 42(2):73-8. PubMed ID: 1972405
[TBL] [Abstract][Full Text] [Related]
53. Long-lasting effects on rheology and clearance of bronchial mucus after short-term administration of high doses of carbocysteine-lysine to patients with chronic bronchitis.
Braga PC; Allegra L; Rampoldi C; Ornaghi A; Beghi G
Respiration; 1990; 57(6):353-8. PubMed ID: 2099568
[TBL] [Abstract][Full Text] [Related]
54. [A complementary experimental method to study agents with mucolytic activity].
Canellas J; Roquebert J; Dufour P; Demichel P
Poumon Coeur; 1977; 33(5):281-5. PubMed ID: 594000
[TBL] [Abstract][Full Text] [Related]
55. Methods for clinical assessment of expectorants: a critical review.
Lurie A; Mestiri M; Huchon G; Marsac J; Lockhart A; Strauch G; Bergogne-Berezin E; Bignon J; Carbon C; Chwalow J
Int J Clin Pharmacol Res; 1992; 12(1):47-52. PubMed ID: 1526698
[TBL] [Abstract][Full Text] [Related]
56. Effects of drugs on mucus glycoproteins and water in bronchial secretion.
Medici TC; Radielovic P
J Int Med Res; 1979; 7(5):434-42. PubMed ID: 40841
[No Abstract] [Full Text] [Related]
57. Effects of orally administered drugs on dynamic viscoelasticity of human nasal mucus.
Majima Y; Hirata K; Takeuchi K; Hattori M; Sakakura Y
Am Rev Respir Dis; 1990 Jan; 141(1):79-83. PubMed ID: 2404442
[TBL] [Abstract][Full Text] [Related]
58. Lack of gastric effects of S-(carboxy-methyl)-L-cysteine.
Domschke W; Domschke S; Demling L
Acta Hepatogastroenterol (Stuttg); 1976 Jun; 23(3):213-5. PubMed ID: 941624
[TBL] [Abstract][Full Text] [Related]
59. The effects of bromhexine hydrochloride and S-carboxymethyl-L-cysteine on guinea-pig uterine microflora.
Malhi JS; Gard PR; Hanlon GW; Marriott C
J Pharm Pharmacol; 1987 Dec; 39(12):1025-8. PubMed ID: 2894430
[TBL] [Abstract][Full Text] [Related]
60. [Effect of mukodin on indices of mucociliary transport].
Solopov VN; Lunichkina IV; Plisko LF; Kolganova NA
Ter Arkh; 1988; 60(12):55-7. PubMed ID: 3247655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
